Robeco Institutional Asset Management B.V. Grows Holdings in Globe Life Inc. (NYSE:GL)

Robeco Institutional Asset Management B.V. grew its position in shares of Globe Life Inc. (NYSE:GL) by 396.7% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 15,025 shares of the company’s stock after buying an additional 12,000 shares during the quarter. Robeco Institutional Asset Management B.V.’s holdings in Globe Life were worth $1,676,000 as of its most recent filing with the SEC.

A number of other large investors also recently bought and sold shares of GL. Versant Capital Management Inc increased its holdings in Globe Life by 388.0% during the 4th quarter. Versant Capital Management Inc now owns 244 shares of the company’s stock valued at $27,000 after acquiring an additional 194 shares in the last quarter. Albion Financial Group UT purchased a new stake in Globe Life in the fourth quarter valued at approximately $28,000. Riverview Trust Co purchased a new stake in Globe Life in the third quarter valued at approximately $32,000. True Wealth Design LLC purchased a new stake in Globe Life in the third quarter valued at approximately $59,000. Finally, Private Trust Co. NA lifted its position in Globe Life by 67.5% during the third quarter. Private Trust Co. NA now owns 670 shares of the company’s stock valued at $71,000 after buying an additional 270 shares in the last quarter. Hedge funds and other institutional investors own 81.61% of the company’s stock.

Globe Life Stock Up 0.2 %

Shares of Globe Life stock opened at $122.38 on Tuesday. The business has a fifty day simple moving average of $112.33 and a 200 day simple moving average of $106.17. The company has a quick ratio of 0.05, a current ratio of 0.05 and a debt-to-equity ratio of 0.50. The stock has a market cap of $10.27 billion, a PE ratio of 10.35 and a beta of 0.81. Globe Life Inc. has a 12 month low of $38.95 and a 12 month high of $132.00.

Globe Life Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, January 31st. Stockholders of record on Monday, January 6th were issued a $0.24 dividend. The ex-dividend date was Monday, January 6th. This represents a $0.96 dividend on an annualized basis and a dividend yield of 0.78%. Globe Life’s dividend payout ratio (DPR) is 8.12%.

Insider Activity

In other news, Director Mark A. Blinn sold 3,000 shares of the stock in a transaction on Monday, January 6th. The stock was sold at an average price of $113.23, for a total value of $339,690.00. Following the completion of the transaction, the director now directly owns 5,122 shares in the company, valued at approximately $579,964.06. This represents a 36.94 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Frank M. Svoboda sold 13,448 shares of the stock in a transaction on Monday, January 6th. The shares were sold at an average price of $112.56, for a total value of $1,513,706.88. Following the completion of the transaction, the chief executive officer now owns 18,948 shares of the company’s stock, valued at $2,132,786.88. The trade was a 41.51 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 39,788 shares of company stock worth $4,429,779 over the last three months. Corporate insiders own 1.51% of the company’s stock.

Wall Street Analyst Weigh In

GL has been the topic of a number of recent research reports. Truist Financial boosted their target price on shares of Globe Life from $90.00 to $105.00 and gave the stock a “hold” rating in a research report on Friday, October 25th. TD Cowen assumed coverage on shares of Globe Life in a report on Wednesday, October 9th. They issued a “buy” rating and a $150.00 price target on the stock. BMO Capital Markets initiated coverage on shares of Globe Life in a research note on Thursday, January 23rd. They set a “market perform” rating and a $114.00 target price for the company. Morgan Stanley upped their price target on shares of Globe Life from $110.00 to $120.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 24th. Finally, Wells Fargo & Company upped their price target on shares of Globe Life from $108.00 to $117.00 and gave the stock an “overweight” rating in a research report on Thursday, October 10th. Five analysts have rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, Globe Life currently has an average rating of “Moderate Buy” and a consensus target price of $132.18.

About Globe Life

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.